---
figid: PMC11855193__ijms-26-01683-g002
figtitle: ApoA-I regulates blood sugar
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11855193
filename: ijms-26-01683-g002.jpg
figlink: /pmc/articles/PMC11855193/figure/F2/
number: F2
caption: 'ApoA-I regulates blood sugar. Apolipoprotein A-I (ApoA-I) exerts effects
  through multiple mechanisms: (i) In skeletal muscle, apoA-I enhances insulin sensitivity
  by activating the insulin receptor substrate 1 (IRS-1)/phosphatidylinositol 3-kinase
  (PI3K)/protein kinase B (AKT) signaling pathway, thereby promoting the translocation
  of glucose transporter type 4 (GLUT4) to the cell membrane. Additionally, AMP-activated
  protein kinase (AMPK) is implicated in these regulatory processes. (ii) In adipose
  tissue, apoA-I activates the IRS-1/PI3K/Akt pathway, facilitates GLUT4 translocation
  to the cell surface, and attenuates inflammation in resident macrophages. (iii)
  In pancreatic β-cells, apoA-I mitigates β-cell loss and maintains β-cell identity
  by upregulating pancreatic duodenal homeobox 1 (Pdx1) expression, inhibiting β-cell
  dedifferentiation into non-insulin-producing cells, and reducing endoplasmic reticulum
  and oxidative stress. (iv) In pancreatic α-cells, apoA-I suppresses excessive glucagon
  production by activating the IRS-PI3K/Akt/forkhead box O1 (FoxO1) pathway'
papertitle: 'High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend
  or Foe?'
reftext: Ke Liu, et al. Int J Mol Sci. 2025 Feb;26(4).
year: '2025'
doi: 10.3390/ijms26041683
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: high-density lipoprotein | cholesterol | type 2 diabetes | diabetic kidney
  disease | chronic kidney disease
automl_pathway: 0.8552107
figid_alias: PMC11855193__F2
figtype: Figure
redirect_from: /figures/PMC11855193__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11855193__ijms-26-01683-g002.html
  '@type': Dataset
  description: 'ApoA-I regulates blood sugar. Apolipoprotein A-I (ApoA-I) exerts effects
    through multiple mechanisms: (i) In skeletal muscle, apoA-I enhances insulin sensitivity
    by activating the insulin receptor substrate 1 (IRS-1)/phosphatidylinositol 3-kinase
    (PI3K)/protein kinase B (AKT) signaling pathway, thereby promoting the translocation
    of glucose transporter type 4 (GLUT4) to the cell membrane. Additionally, AMP-activated
    protein kinase (AMPK) is implicated in these regulatory processes. (ii) In adipose
    tissue, apoA-I activates the IRS-1/PI3K/Akt pathway, facilitates GLUT4 translocation
    to the cell surface, and attenuates inflammation in resident macrophages. (iii)
    In pancreatic β-cells, apoA-I mitigates β-cell loss and maintains β-cell identity
    by upregulating pancreatic duodenal homeobox 1 (Pdx1) expression, inhibiting β-cell
    dedifferentiation into non-insulin-producing cells, and reducing endoplasmic reticulum
    and oxidative stress. (iv) In pancreatic α-cells, apoA-I suppresses excessive
    glucagon production by activating the IRS-PI3K/Akt/forkhead box O1 (FoxO1) pathway'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EBP
  - GLB1
  - SH3D19
  - PDX1
  - PDHX
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SLC2A4
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ebp
  - pdx1
  - irs1
---
